Why PRME? Prime Medicine, Inc. Analysis, Price & AI Insights | Whystock
PRME
$3.44+0.05 (+1.62%)
Market OpenUpdated 2:20 PM EDT
Prime Medicine, Inc., a biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology in the United States.